Gozal et al.35 performed a series of proteomics studies and found that using a panel of uromodulin, urocortin-3, orosomucoid-1, and kallikrein yielded sensitivity (specificity) of 95% (100%) for pediatric OSA. This evidence concerns the gene KLK4 and obstructive sleep apnea syndrome.